Delivery Order SPE2DB22D9367-SPE2DB25FSZ57
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $77,370 by the Defense Logistics Agency's Medical Supply Chain on September 9, 2025. The contract covers the supply of XOLAIR 150 mg/ml syringes, a biologic medication used to treat moderate to severe allergic asthma and chronic idiopathic urticaria. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2025,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 9, 2025, for the supply of Xolair 150 mg/ml syringes. The contract, valued at $1,547.40, operates under a firm fixed-price structure with an ultimate completion date of September 30, 2025. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete on an...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,547.40 by the Defense Logistics Agency (DLA) on August 29, 2025. The delivery order, which has an ultimate completion date of September 22, 2025, is for XOLAIR 150 mg/ml syringes. This award was made without a set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open federal procurement...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,547.40 by the Defense Logistics Agency (DLA) on September 12, 2025, for the supply of Xolair 150 mg/ml syringes. This firm fixed-price delivery order, with an ultimate completion date of October 3, 2025, is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, valued at...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a $1,547.40 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on September 18, 2025, for XOLAIR 75 mg/0.5 mL syringes. The delivery order, which carries an ultimate completion date of October 9, 2025, was issued without a set-aside designation, allowing the company to compete directly in the open market. This award represents a discrete fulfillment...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,642.20 by the Defense Logistics Agency (DLA) on September 4, 2025. The delivery order is for Xolair 150 mg/ml syringes, with an ultimate completion date of September 25, 2025. This award carries no set-aside designation, allowing the vendor to compete on equal footing in the federal procurement marketplace. The place of...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $5,581.44 by the Defense Logistics Agency (DLA) for the supply of Xolair 300 mg/2 ml syringes. The delivery order, issued on September 10, 2025, carries an ultimate completion date of October 1, 2025, with no set-aside designation applied. This award represents a specific task order issued under DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,321.10 by the Defense Logistics Agency (DLA) on August 27, 2025, for the supply of Xolair 150 mg/ml syringes. The contract, awarded without set-aside designation, carries a firm fixed-price structure with an ultimate completion date of September 18, 2025. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,189.60 by the Defense Logistics Agency on September 2, 2025, for the supply of Xolair 150 mg/ml syringes. This firm fixed-price delivery order is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, which carries a potential value of $499,999,999 and remains valid through November...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $7,441.92 by the Defense Logistics Agency on August 13, 2025. The contract calls for the delivery of Xolair 300 mg/2 ml syringes, a biologic medication used primarily for severe allergic asthma and chronic urticaria treatment. This delivery order, which must be completed by September 4, 2025, was issued without a set-aside...
- SPE2DB22D9367Indefinite Delivery Contract
- SPE2DB22D9367-SPE2DB25FSZ57Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $9,284.40 by the Defense Logistics Agency (DLA) on September 2, 2025. The delivery order is for XOLAIR 150 mg/ml syringes, a biologic medication used primarily for moderate to severe allergic asthma treatment. This award was issued without a set-aside designation, demonstrating the contractor's competitive positioning in the federal pharmaceutical procurement market. The place of performance is Park Ridge, Illinois, with an ultimate completion date of September 23, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion contract vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities worldwide. The IDC positions DMS Pharmaceutical Group as a key supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and specialty medications to military health facilities. The company's extensive contract portfolio with DLA demonstrates its established capability to deliver branded biologics, specialty pharmaceuticals, and other medical products efficiently to support DoD healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.3k | 9/2/25 |